Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Sep 13;1(3):122-123.
doi: 10.1089/psymed.2023.29002.psh. eCollection 2023 Sep.

The Elephant in the Room: Personal Use of Psychedelics Among Psychedelic Researchers

Affiliations
Editorial

The Elephant in the Room: Personal Use of Psychedelics Among Psychedelic Researchers

Peter S Hendricks et al. Psychedelic Med (New Rochelle). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

P.S.H. was previously in a paid advisory relationship with Silo Pharma and is currently in paid advisory relationships with the following organizations regarding the development of psychedelics and related compounds: Bright Minds Biosciences Ltd., Eleusis Benefit Corporation, Journey Colab Corporation, and Reset Pharmaceuticals, Inc. C.D.N. is a venture partner with Palo Santo, founder of 2A Biosciences, and a board member of the Heffter Research Institute.No funding was received for this article.

References

    1. Pagán AF, Lex C, Soares JC, et al. Medical students' attitudes and beliefs toward psilocybin: Does terminology and Personal experience with psychedelics matter? Psychedelic Med 2023;1:130–138.
    1. Herrmann Z, Levin AW, Cole SP, et al. Psychedelic use among psychiatric medication prescribers: Effects on well-being, depression, anxiety, and associations with patterns of use, reported harms, and transformative mental states. Psychedelic Med 2023;1:139–149.
    1. Aday JS, Skiles Z, Eaton N, et al. Personal psychedelic use is common among a sample of psychedelic therapists: Implications for research and practice. Psychedelic Med 2023;1:27–37.
    1. Osmond H. A review of the clinical effects of psychotomimetic agents. Ann N Y Acad Sci 1957;66:418–434. - PubMed
    1. Hofmann A. LSD: My Problem Child. Oxford University Press: Oxford, UK; 2013.

Publication types

LinkOut - more resources